0001840498-21-000001.txt : 20210115
0001840498-21-000001.hdr.sgml : 20210115
20210115140755
ACCESSION NUMBER: 0001840498-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210115
DATE AS OF CHANGE: 20210115
EFFECTIVENESS DATE: 20210115
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gatehouse Bio, Inc.
CENTRAL INDEX KEY: 0001840498
IRS NUMBER: 812225637
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-386501
FILM NUMBER: 21531338
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DR.
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 267-858-7631
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DR.
CITY: WALTHAM
STATE: MA
ZIP: 02451
D
1
primary_doc.xml
X0708
D
LIVE
0001840498
Gatehouse Bio, Inc.
35 Gatehouse Drive
WALTHAM
MA
MASSACHUSETTS
02451
(339) 707-7763
DELAWARE
sRNAlytics, Inc.
None
Corporation
true
2017
David
W.
Salzman, Ph.D.
c/o Gatehouse Bio, Inc.
35 Gatehouse Drive
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Director
Neal
Foster
c/o Gatehouse Bio, Inc.
35 Gatehouse Drive
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-12-31
false
true
false
0
5445379
5445379
0
The Total Offering Amount includes the conversion of certain convertible securities previously issued by the Issuer.
false
28
0
0
0
false
Gatehouse Bio, Inc.
/s/ David W. Salzman, Ph.D.
David W. Salzman, Ph.D.
Chief Executive Officer
2021-01-15